Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1Classical hematology 1

Conditions

Venous Thromboembolism 2Thrombosis 2Hemorrhage 2Venous Thrombosis 1Thromboembolism 1Thrombocytopenia 1Sarcoma 1Pulmonary Embolism 1Pancreatic Neoplasms 1Liver Neoplasms 1Hematoma 1Head and Neck Neoplasms 1Gastrointestinal Neoplasms 1Fibrosis 1Carcinoma, Hepatocellular 1Bone Neoplasms 1

Interventions

Cisplatin 4Morphine 3Fluorouracil 3Fentanyl 3Norepinephrine 2Gabapentin 2Docetaxel 2Cetuximab 2technetium-diethylenetriaminepentaacetic acid-mannosyl-dextran 1technetium Tc 99m nanocolloid 1nimotuzumab 1dopexamine 1apixaban 1Venlafaxine Hydrochloride 1Tobacco Use Cessation Devices 1Taste 1Sugars 1Saline Solution 1Radiotherapy, Intensity-Modulated 1Radiosurgery 1Psychiatric Rehabilitation 1Pregabalin 1Polymerase Chain Reaction 1Patient-Specific Modeling 1Oxycodone 1Oral Hygiene 1Neck Dissection 1Mitomycin 1Mirtazapine 1Methadone 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 4 × Head and Neck Neoplasms × Enoxaparin × Clear all
NCT07189897 2025-10-08

Apixaban or Enoxaparin After Head and Neck Cancer Surgery

State University of New York - Upstate Medical University

Phase 4 Recruiting
76 enrolled
Classical hematologyHead & Neck

Head and Neck Neoplasms, Thrombosis, Venous Thromboembolism

Data powered by HemOnc (CC BY 4.0) Colophon âš¡